INTRODUCTION INTRODUCTION
The influence of the pharmaceutical indusThe influence of the pharmaceutical industry on academic medicine is pervasive. Altry on academic medicine is pervasive. Almost 90% of authors published in the most 90% of authors published in the Journal of the American Medical AssociaJournal of the American Medical Association tion have received research funding from, have received research funding from, or acted as a consultant for, a drug comor acted as a consultant for, a drug company. Rising to this challenge, editors of pany. Rising to this challenge, editors of medical journals have agreed strict rules medical journals have agreed strict rules on reporting sponsorship and conflicts of on reporting sponsorship and conflicts of interest. Academic psychiatry is not exempt interest. Academic psychiatry is not exempt from the influence of industry. The refrom the influence of industry. The relationship between drug companies and lationship between drug companies and academic psychiatry is currently very close. academic psychiatry is currently very close. But is this a problem? On the one hand, But is this a problem? On the one hand, links with the pharmaceutical industry links with the pharmaceutical industry may be considered to compromise the indemay be considered to compromise the independence of researchers and possibly dispendence of researchers and possibly discredit their published work. On the other credit their published work. On the other hand the relationship may be seen as prohand the relationship may be seen as productive and mutually beneficial -particuductive and mutually beneficial -particularly in an era of limited funds for larly in an era of limited funds for research. These issues are discussed in this research. These issues are discussed in this month's debate by Dr David Healy, Direcmonth's debate by Dr David Healy, Director of the North Wales Psychiatric Service tor of the North Wales Psychiatric Service who is a well-known commentator on the who is a well-known commentator on the pharmaceutical industry, and Dr Michael pharmaceutical industry, and Dr Michael Thase, Professor of Psychiatry at the UniThase, Professor of Psychiatry at the University of Pittsburgh School of Medicine versity of Pittsburgh School of Medicine and the author of a meta-analysis on the efand the author of a meta-analysis on the effectiveness of venlafaxine published in this fectiveness of venlafaxine published in this Journal in 2001. Journal in 2001.
FOR FOR
For the media it must be like shooting goldFor the media it must be like shooting goldfish in a bowl. Go along to an international fish in a bowl. Go along to an international meeting, wait for psychiatrists coming out meeting, wait for psychiatrists coming out of the exhibition halls laden with pens, of the exhibition halls laden with pens, mugs, kites and CDs, in a relaxed frame mugs, kites and CDs, in a relaxed frame of mind having had their massage done or of mind having had their massage done or their portrait painted, and ask: Does this their portrait painted, and ask: Does this not influence you? Our answer invariably not influence you? Our answer invariably is: No. How could this have much effect is: No. How could this have much effect on us -we follow the evidence. on us -we follow the evidence.
Exchanges like this are predicated on a Exchanges like this are predicated on a failure on the part of clinicians to distinfailure on the part of clinicians to distinguish between sales and marketing. Sales guish between sales and marketing. Sales is the subdivision of marketing responsible is the subdivision of marketing responsible for producing all those things that fail to for producing all those things that fail to influence clinicians, from advertising in influence clinicians, from advertising in journals or on pens and mugs to 'directjournals or on pens and mugs to 'directto-consumer' television slots. The sales to-consumer' television slots. The sales department swings into action close to the department swings into action close to the launch of a drug. But the marketing departlaunch of a drug. But the marketing department starts once a compound has been disment starts once a compound has been discovered. Marketing decides whether a new covered. Marketing decides whether a new drug will be an antidepressant rather than drug will be an antidepressant rather than an anxiolytic or a treatment for premature an anxiolytic or a treatment for premature ejaculation. Marketing determines which ejaculation. Marketing determines which journals with which lead authors clinical journals with which lead authors clinical trials will appear in. Marketing recruits trials will appear in. Marketing recruits academics, including geneticists, neuroacademics, including geneticists, neuroimaging specialists and social psychiatrists, imaging specialists and social psychiatrists, to consultancy and speaker panels, and to consultancy and speaker panels, and makes friends for the company. The marmakes friends for the company. The marketing department supports educational keting department supports educational events by putting on symposia, sponsoring events by putting on symposia, sponsoring speakers and bringing psychiatrists to interspeakers and bringing psychiatrists to international meetings. The work of the marketnational meetings. The work of the marketing departments is to create 'evidence' and ing departments is to create 'evidence' and establish consensus. establish consensus.
In the past year major journals have In the past year major journals have expressed concern at the ghostwriting of expressed concern at the ghostwriting of and conflicting interests surrounding pharand conflicting interests surrounding pharmacotherapeutic studies, especially in psymacotherapeutic studies, especially in psychiatry (Carpenter, 2002; Torrey, 2002) . chiatry (Carpenter, 2002; Torrey, 2002) . Some will see this as a set of minor critiSome will see this as a set of minor criticisms of excesses in an otherwise smoothly cisms of excesses in an otherwise smoothly functioning set of relations between acadefunctioning set of relations between academia and industry. Others clearly see mia and industry. Others clearly see emerging evidence of some unsuspected emerging evidence of some unsuspected dimensions to a very successful industrial dimensions to a very successful industrial process. process.
The origins of this industrial process lie The origins of this industrial process lie in the 1950s, when patients' access to new in the 1950s, when patients' access to new drugs was constrained within a system initidrugs was constrained within a system initially devised for addicts -prescription-only ally devised for addicts -prescription-only medicines. A gain in safety was the hopedmedicines. A gain in safety was the hopedfor trade-off from this curtailment of liberfor trade-off from this curtailment of liberties -physicians would know what data ties -physicians would know what data were missing and what studies were needed were missing and what studies were needed to make a proper assessment of the risks to make a proper assessment of the risks and benefits of treatments, and they would and benefits of treatments, and they would force companies to supply the data and the force companies to supply the data and the studies. The system appeared to work studies. The system appeared to work when, following the thalidomide crisis a when, following the thalidomide crisis a few years later, academics succeeded in few years later, academics succeeded in setting the eye of a randomised controlled setting the eye of a randomised controlled trial needle in front of the industrial camel trial needle in front of the industrial camel (Healy, 2002) . (Healy, 2002) .
It was not anticipated, however, that It was not anticipated, however, that restricted to selling their compounds for restricted to selling their compounds for disease entities and to physicians, compadisease entities and to physicians, companies would sell diseases and devote vast nies would sell diseases and devote vast resources to educating physicians -roughly resources to educating physicians -roughly £10 000 per annum per physician. Few £10 000 per annum per physician. Few could have expected in the 1960s that could have expected in the 1960s that companies would be able to market evicompanies would be able to market evidence of treatment effects from a minority dence of treatment effects from a minority of studies, as in the case of the selective of studies, as in the case of the selective serotonin reuptake inhibitors, as evidence serotonin reuptake inhibitors, as evidence of treatment efficacy, or that such evidence of treatment efficacy, or that such evidence would be sufficient to lead to blockbuster would be sufficient to lead to blockbuster status for these drugs. status for these drugs.
The ability of companies to confound The ability of companies to confound the expectations of those who would conthe expectations of those who would constrain them lies in a restructuring largely strain them lies in a restructuring largely effected in the 1970s. This restructuring effected in the 1970s. This restructuring led to a separation between sales and led to a separation between sales and marketing. It led to the establishment of marketing. It led to the establishment of contract research organisations, which recontract research organisations, which replaced universities as the organisers of placed universities as the organisers of clinical trials. It led to medical writing clinical trials. It led to medical writing agencies who now write the first and, often, agencies who now write the first and, often, all drafts of key review or clinical trial all drafts of key review or clinical trial articles. This is a process to which senior articles. This is a process to which senior academics increasingly make ornamental academics increasingly make ornamental rather substantive contributions. rather substantive contributions.
From these new arrangements stems the From these new arrangements stems the evidence clinicians seem to think keeps evidence clinicians seem to think keeps them safe on the academic high ground. them safe on the academic high ground. However, between the collection of data However, between the collection of data in clinical trials and its presentation to in clinical trials and its presentation to clinicians there are a number of key interclinicians there are a number of key interventions. First, companies regard trial data ventions. First, companies regard trial data as proprietary. Clinicians only ever get as proprietary. Clinicians only ever get presented with subsets of the data. Second, presented with subsets of the data. Second, this selection of data gets called science and this selection of data gets called science and appears in the most prestigious journals appears in the most prestigious journals and under the apparent authorship of and under the apparent authorship of 1 1
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Is academic psychiatry for sale? Is academic psychiatry for sale?
DAVID HEALY / MICHAEL THASE DAVID HEALY / MICHAEL THASE leading figures in the field. It certainly has leading figures in the field. It certainly has the appearances of science, but it is a the appearances of science, but it is a cuckoo's egg in the nest of science. cuckoo's egg in the nest of science. For data to be scientific they must in For data to be scientific they must in principle be available for scrutiny. Ideally principle be available for scrutiny. Ideally they should be generated in the process of they should be generated in the process of answering scientific questions. Neither of answering scientific questions. Neither of these conditions is fulfilled by these busithese conditions is fulfilled by these business exercises. If there were any suspicions ness exercises. If there were any suspicions of significant discrepancies between the of significant discrepancies between the published and the collected data, one published and the collected data, one would expect an independent academic would expect an independent academic establishment to object. At the very least, establishment to object. At the very least, one might expect published evidence of one might expect published evidence of major discrepancies to be greeted with the major discrepancies to be greeted with the disengagement of academic psychiatrists disengagement of academic psychiatrists from company platforms. In fact, the most from company platforms. In fact, the most senior figures in academia are likely to be senior figures in academia are likely to be found endorsing the product. found endorsing the product.
Claiming the data is proprietary might Claiming the data is proprietary might be acceptable if companies restricted their be acceptable if companies restricted their marketing to the time-honoured sales marketing to the time-honoured sales strategies of clinician freebies and celebrity strategies of clinician freebies and celebrity endorsements. But one might have expected endorsements. But one might have expected an independent academic establishment to an independent academic establishment to force companies to abide by the rules of force companies to abide by the rules of science, if 'science' is used as a marketing science, if 'science' is used as a marketing strategy. Academia should surely at least strategy. Academia should surely at least be able to emulate successful consumer be able to emulate successful consumer organisations in other marketplaces in organisations in other marketplaces in pointing to mismatches between evidence pointing to mismatches between evidence and hype -this at least was clearly the and hype -this at least was clearly the expectation of politicians, regulators and expectation of politicians, regulators and the public in the 1960s. the public in the 1960s.
Unlike the pens and mugs, clinicians do Unlike the pens and mugs, clinicians do not have the option of taking or leaving not have the option of taking or leaving these products of company marketing these products of company marketing departments. The fact that these 'infodepartments. The fact that these 'infomercials' appear in all the best journals mercials' appear in all the best journals has consequences. The fact that these data has consequences. The fact that these data selections become embodied in algorithms selections become embodied in algorithms and protocols constructed by panels of and protocols constructed by panels of academics has consequences, even though academics has consequences, even though the interests of these academics, when the interests of these academics, when scrutinised, are revealing. Clinicians are as scrutinised, are revealing. Clinicians are as dependent on their academics in this new dependent on their academics in this new marketplace as the public is on their marketplace as the public is on their clinicians. clinicians.
At present, journal editors seem to be At present, journal editors seem to be the fall guys who, equipped with the the fall guys who, equipped with the shovels of conflict of interest statements shovels of conflict of interest statements and the brooms of authorship declarations, and the brooms of authorship declarations, are expected to clean out the Augean are expected to clean out the Augean stables of an increasingly compromised stables of an increasingly compromised academic literature, when what is needed academic literature, when what is needed is a breach in the dam of academic silence is a breach in the dam of academic silence and a flood of refusals to accept that and a flood of refusals to accept that publications that involve data that are not publications that involve data that are not publicly available should be called scientipublicly available should be called scientific. A failure to take a stand will leave us fic. A failure to take a stand will leave us repeatedly cuckolded by every issue of our repeatedly cuckolded by every issue of our major journals. major journals. 
AGAINST AGAINST
Academic psychiatry is not for sale. HowAcademic psychiatry is not for sale. However, the labours of academic psychiatrists, ever, the labours of academic psychiatrists, like those of barristers, stone masons, like those of barristers, stone masons, plumbers, or engineers are exchanged for plumbers, or engineers are exchanged for money every day, everywhere. money every day, everywhere.
In the USA, at least, virtually no departIn the USA, at least, virtually no departmental support is available to underwrite mental support is available to underwrite research and, increasingly, external funds research and, increasingly, external funds are necessary. The pharmaceutical industry are necessary. The pharmaceutical industry has been a relatively consistent source of has been a relatively consistent source of funding -if the investigator is willing to funding -if the investigator is willing to study a topic of interest to the potential study a topic of interest to the potential sponsor. This is preferable to indentured sponsor. This is preferable to indentured servitude. However, industry-funded reservitude. However, industry-funded research is almost universally regarded by search is almost universally regarded by academicians as less prestigious or less academicians as less prestigious or less important -authorship opportunities are important -authorship opportunities are limited and papers typically receive lower limited and papers typically receive lower marks in objectivity or quality (Rochon marks in objectivity or quality (Rochon et et al, al, 1994 (Rochon et et al, al, , 2002 . Consequently, many other 1994, 2002). Consequently, many other scholarly activities will have a higher career scholarly activities will have a higher career pay-off. pay-off.
Should individual academics be perShould individual academics be permitted to sell their services to the pharmamitted to sell their services to the pharmaceutical industry? Discussion can be ceutical industry? Discussion can be guided by established legal, moral and guided by established legal, moral and ethical principles. At the most explicit level, ethical principles. At the most explicit level, if the terms of employment between the if the terms of employment between the academic and his or her employer forbid academic and his or her employer forbid collaboration with the pharmaceutical incollaboration with the pharmaceutical industry, the academic must obtain a new dustry, the academic must obtain a new contract or employer before initiating such contract or employer before initiating such work. If these services are not proscribed, work. If these services are not proscribed, then there is no legal problem. then there is no legal problem.
Academics working with the pharmaAcademics working with the pharmaceutical industry may be chastised on moral ceutical industry may be chastised on moral or ethical grounds. The moral high ground or ethical grounds. The moral high ground rapidly transforms into a slippery slope, rapidly transforms into a slippery slope, however, if value judgements are mistaken however, if value judgements are mistaken for ethical standards. One person may for ethical standards. One person may consider that a colleague's collaboration consider that a colleague's collaboration with the pharmaceutical industry reflects with the pharmaceutical industry reflects greed, but another may judge the critic to greed, but another may judge the critic to be envious or sanctimonious. Is greed inbe envious or sanctimonious. Is greed inherently worse than envy? Is it immoral herently worse than envy? Is it immoral for an academician to work with the for an academician to work with the pharmaceutical industry? If one accepts impharmaceutical industry? If one accepts immoral behaviour as a violation of accepted moral behaviour as a violation of accepted or established principles of goodness (i.e. or established principles of goodness (i.e. choosing between agreed definitions of choosing between agreed definitions of right and wrong) then the answer must be right and wrong) then the answer must be
Collaborations between universityCollaborations between universitybased researchers and various industries based researchers and various industries exist across disciplines. Indeed, more than exist across disciplines. Indeed, more than half of all clinical research is funded by half of all clinical research is funded by the pharmaceutical industry (Saver the pharmaceutical industry (Saver et al, et al, 2002) . It would be difficult to develop 2002). It would be difficult to develop and maintain expertise without, at some and maintain expertise without, at some point, working with drug companies. In point, working with drug companies. In fact, the vast majority of experts selected fact, the vast majority of experts selected to develop clinical practice guidelines have to develop clinical practice guidelines have some financial relationships with the some financial relationships with the pharmaceutical industry, typically includpharmaceutical industry, typically including some of the medications being evaluing some of the medications being evaluated in those guidelines (Choudhry ated in those guidelines (Choudhry et al, et al, 2002) . Is this a shocking revelation? No -2002) . Is this a shocking revelation? Noacademics are selected to work on guideline academics are selected to work on guideline panels precisely because of their expertise, panels precisely because of their expertise, which typically includes experience conductwhich typically includes experience conducting industry-sponsored clinical research. Is ing industry-sponsored clinical research. Is this evidence that we are 'on the take'? No this evidence that we are 'on the take'? No -the pharmaceutical industry is virtually -the pharmaceutical industry is virtually the only source of discovery and developthe only source of discovery and development of novel therapeutic compounds. ment of novel therapeutic compounds.
In this era of government limits on In this era of government limits on health-care spending, many are understandhealth-care spending, many are understandably critical of the profits made by 'big ably critical of the profits made by 'big pharma', but to suggest that it is wrong to pharma', but to suggest that it is wrong to work with the industry because it is profitwork with the industry because it is profitable (Anonymous, 2002) appears to conable (Anonymous, 2002) appears to confuse personal opinion with morals. After fuse personal opinion with morals. After all, the same industry is permitted to buy all, the same industry is permitted to buy advertising space in our journals. advertising space in our journals.
It is not unethical to be paid to consult It is not unethical to be paid to consult with, or conduct research funded by drug with, or conduct research funded by drug companies It could even be argued that it companies It could even be argued that it is unethical to deny our expertise to the is unethical to deny our expertise to the industry that develops new treatments. If industry that develops new treatments. If work is performed but the prospect of rework is performed but the prospect of receiving industry funding is too heinous to ceiving industry funding is too heinous to contemplate, income could always be contemplate, income could always be donated to charities. It could also be donated to charities. It could also be considered 'ethical' to provide professional considered 'ethical' to provide professional services gratis to a for-profit business services gratis to a for-profit business (although here the term 'foolish' comes to (although here the term 'foolish' comes to mind). mind).
Having established that it is not unlawHaving established that it is not unlawful, immoral or unethical to work with ful, immoral or unethical to work with pharmaceutical industry, there is little pharmaceutical industry, there is little doubt that some academics behave unethidoubt that some academics behave unethically, dishonourably or even illegally in cally, dishonourably or even illegally in these relations, although there is no evithese relations, although there is no evidence that the risk of scientific misconduct dence that the risk of scientific misconduct in industry-sponsored clinical research is in industry-sponsored clinical research is any greater than that in more prestigious, any greater than that in more prestigious, federally funded studies. The potential for federally funded studies. The potential for industry-related conflicts is endemic. There industry-related conflicts is endemic. There
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is evidence that even relatively modest is evidence that even relatively modest 'favours' from the pharmaceutical industry 'favours' from the pharmaceutical industry can affect physician behaviour (Campbell can affect physician behaviour (Campbell et al, et al, 1998; Smith, 1998; Wazana, 2000 Wazana, ). 1998 Smith, 1998; Wazana, 2000) . It is also true that it is easier to document It is also true that it is easier to document potential conflicts of interest when money potential conflicts of interest when money changes hands than when the conflict is changes hands than when the conflict is ideological or personal (Kjaergard & Alsideological or personal (Kjaergard & AlsNielsen, 2002 ) Nielsen, 2002 Guidelines are continuously evolving to Guidelines are continuously evolving to help academics to behave ethically in their help academics to behave ethically in their relations with drug companies. At present, relations with drug companies. At present, the most widely endorsed ethical standard the most widely endorsed ethical standard is transparency (i.e. explicit reporting of is transparency (i.e. explicit reporting of relationships with the pharmaceutical inrelationships with the pharmaceutical industry). This is not foolproof, however, dustry). This is not foolproof, however, and dishonest individuals can simply lie and dishonest individuals can simply lie about the nature and extent of their relaabout the nature and extent of their relationships with industry. Honest mistakes tionships with industry. Honest mistakes can also happen. There is a shadowy can also happen. There is a shadowy boundary between industry-funded promoboundary between industry-funded promotional activities and those that qualify for tional activities and those that qualify for continuing medical education credits. continuing medical education credits.
There are a number of grey areas and There are a number of grey areas and complexities. For example, can one peercomplexities. For example, can one peerreview a paper reporting research findings review a paper reporting research findings if one has received funding from a comif one has received funding from a company that manufactures a rival compound pany that manufactures a rival compound (Mowatt (Mowatt et al et al, 2002) ? What if the funding , 2002)? What if the funding was from a formerly unrelated company was from a formerly unrelated company that has now merged? Current standards that has now merged? Current standards should not be used to judge activities that should not be used to judge activities that may have appeared above-board a decade may have appeared above-board a decade earlier. In today's 'affectively charged' cliearlier. In today's 'affectively charged' climate, simply pointing out a relationship mate, simply pointing out a relationship with the pharmaceutical industry seems to with the pharmaceutical industry seems to be sufficient grounds to challenge the be sufficient grounds to challenge the results of a study. results of a study.
I hope that we come to our senses and I hope that we come to our senses and exercise some collective good judgement exercise some collective good judgement before rigid regulations or reactionary polibefore rigid regulations or reactionary policies are developed to try to safeguard our cies are developed to try to safeguard our integrity. Even an ideal regulatory system integrity. Even an ideal regulatory system must depend on the integrity of individual must depend on the integrity of individual investigators (Miller investigators (Miller et al et al, 1998) . I humbly , 1998). I humbly suggest that each of us be held accountable suggest that each of us be held accountable for our integrity. I suggest that academics for our integrity. I suggest that academics hold the products of their industry-funded hold the products of their industry-funded efforts to the highest standard of conduct. efforts to the highest standard of conduct. Towards this end, I encourage journal reTowards this end, I encourage journal reviewers to question possible bias whenever viewers to question possible bias whenever it is suspected. If a continuing education it is suspected. If a continuing education talk appears to be too 'lopsided', challenge talk appears to be too 'lopsided', challenge the speaker and write negative comments. I the speaker and write negative comments. I embrace the reader's right to disagree and embrace the reader's right to disagree and respect that academic psychiatrists may respect that academic psychiatrists may value completely different endeavours. I value completely different endeavours. I accept that some of this Journal's readers accept that some of this Journal's readers will presume that my work is biased will presume that my work is 
